Start your Pilot Run
Generate real data to validate feasibility and workflow before full-scale studies. Access pilot studies for Olink® Reveal, and Mass Spectrometry on the Thermo Orbitrap Astral/ Orbitrap Exploris™ 120.

20 complimentary pilot runs available. Participants not selected for a pilot run may still qualify for a 20% service discount.
Why Proteomics and Metabolomics?
Genomics tells you what could happen.
Proteomics shows what is actively happening.
Metabolomics reveals the final biological outcome.

By connecting molecular mechanisms to phenotype, proteomics and metabolomics transform complex biology into insights you can act on.

Our Pilot Run Offer for Mass Spectrometry on the Thermo Orbitrap Astral/ Orbitrap Exploris 120™ and Olink® Reveal generates real experimental data to support confident study design and informed decision-making. Explore the platforms and services offered by Novogene.
Mass Spectrometry Pilot Details

Olink Reveal Pilot Details


Mass Spectrometry Pilot Details
Novogene’s mass spectrometry services combine high-resolution LC-MS with robust workflows to deliver reproducible proteomics and metabolomics data. Powered by the Orbitrap Exploris™ 120 and Thermo Orbitrap Astral, these services support untargeted metabolomics and library-free DIA proteomics, and are well suited for feasibility testing and workflow evaluation before full-scale studies.


Sample & Study Design Guidance
Our scientific team will review your study goals and advise on:

  • Platform suitability
  • Sample requirements
  • Experimental design considerations
Olink® Reveal Pilot Details
Novogene is a certified global service provider for Olink exploratory series Explore HT and Reveal, offering scalable protein profiling using Proximity Extension Assay (PEA) technology. This approach combines antibody specificity with high sensitivity, enabling reliable detection of low-abundance proteins from minimal sample volumes.

Olink Reveal is widely applied in translational and clinical research, supporting biomarker discovery, pathway-level analysis, and hypothesis validation where sample availability may be limited.
Workflow
Sample Requirements
Unlock Proteomics & Metabolomics Insights!
Dive into the world of integrated multi-omics with Dr. Novo, and explore how different omics platforms connect to reveal deeper biological insights.

If a pilot run isn’t the right fit at the moment, take part in our 60-second challenge to earn Genomiles. The top 8 highest-scoring participants will receive prizes valued at up to USD 200 each.


Apply for a Pilot Run

Indicate your interest in a pilot run, share basic project details and connect with a Novogene expert.

Project Information

Please indicate 1) Service of Pilot Run Interest: Mass Spectrometry/ Olink Reveal, 2) Sample Type & Qty, 3) Sample Readiness
By registering on this page, you are consenting and agreeing for Novogene to contact you, assist with your request, and store your information per our privacy policy. You can change your email preferences at any time.
Eligibility and Terms of Pilot Run Offer

  1. The Pilot Run Offer is for research use only and applies to AMEA (Asia Pacific, Middle East & Africa) clients for Olink® Proteomics Reveal services. Mass Spectrometry services are available only to customers in Southeast Asia, Taiwan, Hong Kong and South Korea.
  2. A total of 10 winners will be selected for Olink® Proteomics Reveal pilot runs and 10 winners for Mass Spectrometry pilot runs, each comprising six samples.
  3. This Pilot Run Offer is applicable from 9 February to 31 March 2026. Winners of the pilot run study must submit a purchase order (PO), and samples must be received at the lab by 31 May 2026.
  4. Free pilot runs include standard services only and do not cover customized or value-added services. For additional pricing details, please contact your representative when requesting a quote.
  5. Promotion details are subject to change. Novogene reserves the right to interpret and amend these terms and conditions as necessary.
 
 
 
About Novogene
Novogene is a pioneer in applying cutting-edge molecular biology technology and high-performance computing to research in the fields of life science and human health. Our vision is to continue as a global leader in the delivery of genomics services and solutions. With one of the largest sequencing capacities in the world, we utilise our deep scientific knowledge, first-class customer service and unsurpassed data quality to help clients realise their research goals in the rapidly evolving world of genomics. Novogene is committed to become your trusted genomics partner.
 
For more information, visit novogene.com/amea-en
in   N   X   X   f
© 2026 Novogene Co., Ltd. All Rights Reserved.
For Research Use Only. Not for Clinical Diagnostic Use.
Regional Office for Asia Pacific, Middle-East & Africa:
NovogeneAIT Genomics Pte. Ltd.
11 Biopolis Way, #10-11 Helios,
Singapore 138667  
 
Novogene (HK) Company Limited
Unit 1307, Everglory Centre,
1B Kimberly Street, 
Tsim Sha Tsui, Hong Kong
Novogene Japan K.K.
Kayabacho-Nagaoka BLDG3-7F, 2-7-10,
Nihonbashi-Kayabacho, Chuo City,
Tokyo,103-0025 Japan
 
Novogene Korea
Mediopen Lab 503, 5th Floor,
Korea Health Management Association,
372 Hwagok-ro, Gangseo-gu,
Seoul, Republic of Korea